O

Optomed Oyj
OMXH:OPTOMED

Watchlist Manager
Optomed Oyj
OMXH:OPTOMED
Watchlist
Price: 3.955 EUR -0.25% Market Closed
Market Cap: 76.2m EUR
Have any thoughts about
Optomed Oyj?
Write Note

Optomed Oyj
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Optomed Oyj
Gross Profit Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
O
Optomed Oyj
OMXH:OPTOMED
Gross Profit
€10.2m
CAGR 3-Years
5%
CAGR 5-Years
5%
CAGR 10-Years
N/A
R
Revenio Group Oyj
OMXH:REG1V
Gross Profit
€50.3m
CAGR 3-Years
10%
CAGR 5-Years
18%
CAGR 10-Years
26%
M
Modulight Oyj
OMXH:MODU
Gross Profit
€5m
CAGR 3-Years
-23%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
B
Bioretec Oy
OMXH:BRETEC
Gross Profit
€2.7m
CAGR 3-Years
35%
CAGR 5-Years
20%
CAGR 10-Years
N/A
N
Nexstim Oyj
OMXH:NXTMH
Gross Profit
€7.7m
CAGR 3-Years
18%
CAGR 5-Years
29%
CAGR 10-Years
N/A
B
Biohit Oyj
OMXH:BIOBV
Gross Profit
€8.6m
CAGR 3-Years
21%
CAGR 5-Years
5%
CAGR 10-Years
24%
No Stocks Found

Optomed Oyj
Glance View

Market Cap
77.5m EUR
Industry
Health Care

Optomed Oyj engages in the provision of handheld fundus cameras and eye-screening solutions. The company is headquartered in Oulu, Oulun and currently employs 115 full-time employees. The company went IPO on 2019-12-09. The Group's Parent Company, Optomed Oyj, is responsible for, among other things, the management of the Group as well as finance and accounting functions, human resources, legal affairs and corporate communication. The Group's business is managed through two reportable segments: Devices and Software. The Devices segment develops, commercializes and manufactures easy-to-use and affordable handheld fundus cameras. The Software segment develops and sells screening software for diabetic retinopathy and cancer screening for healthcare organizations. The Optomed Group consists of the parent company Optomed Oyj and four subsidiaries in Finland, China, the USA and Hong Kong.

OPTOMED Intrinsic Value
5.584 EUR
Undervaluation 29%
Intrinsic Value
Price
O

See Also

What is Optomed Oyj's Gross Profit?
Gross Profit
10.2m EUR

Based on the financial report for Dec 31, 2023, Optomed Oyj's Gross Profit amounts to 10.2m EUR.

What is Optomed Oyj's Gross Profit growth rate?
Gross Profit CAGR 5Y
5%

Over the last year, the Gross Profit growth was 11%. The average annual Gross Profit growth rates for Optomed Oyj have been 5% over the past three years , 5% over the past five years .

Back to Top